Contracts

  • Study of the antihyperalgesic responses induced by the oral administration of PL265 in a model of bone cancer-induced pain in mice. Search of a possible synergistc potentiation by the administration of gabapentin or the CB2 selective agonist, AM1241 [FUO-EM-111-09]

    Organism: PHARMALEADS

    Start Date:
    18 of March of 2009
    End Date:
    17 of March of 2010
    Lead Research:
    • Luis Menéndez Antolín
    • Ana Baamonde Arbaiza